Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities
Net loss	$ (122,693)	$ (52,500)
Adjustments to reconcile net loss to net cash used in operating activities
Allowance for credit losses - Accounts receivable, net	1,756	1,761
Allowance for credit losses - Contract assets, net	2,337	0
Depreciation and amortization	19,460	28,242
Amortization of right-of-use assets	648	937
(Gain) loss on disposal of assets	(3)	7
Impairment of goodwill	49,390	0
Impairment of intangible assets	16,744	21,570
Lease restructuring charges	0	438
Loss on termination of operations	869	0
Stock-based compensation, net of amounts capitalized	3,051	6,656
Interest expense paid-in-kind	23,482	0
Amortization of debt issuance costs	2,398	1,490
Deferred income tax benefit, net	(798)	(4,108)
Change in fair value of contingent consideration	(1,905)	2,583
Change in fair value of warrant liabilities	(9,185)	(3,360)
Loss from preferred warrants issuance	553	0
Change in Tax Receivable Agreement liability	0	(1,146)
Change in income tax receivable and payable	(167)	9
Change in accounts receivable	17,942	1,984
Change in contract assets	(10,436)	0
Change in prepaid expenses and other current assets	798	416
Change in operating right-of-use assets	757	0
Change in accounts payable and accrued expenses	(735)	(3,055)
Change in operating lease liabilities	(2,143)	(2,102)
Change in other liabilities	0	(137)
Net cash used in operating activities	(7,880)	(315)
Cash flows from investing activities
Additions to property and equipment	(6,624)	(6,744)
Acquisition of business, net of cash acquired	(33,564)	(2,502)
Net cash used in investing activities	(40,188)	(9,246)
Cash flows from financing activities
Proceeds from borrowings on revolving credit facilities	10,000	40,000
Payments of long-term debt and notes payable	(2,250)	(2,250)
Payments of borrowings on revolving credit facilities	(250)	0
Payment of debt issuance costs	(1,928)	0
Proceeds from preferred shares and warrants issuance, net	13,107	0
Purchase of treasury stock related to stock-based compensation	(54)	(181)
Distributions to non-controlling interest holders	0	(563)
Payment of deferred consideration and contingent consideration payable	(428)	(5,000)
Net cash provided by financing activities	18,197	32,006
Net change in cash and cash equivalents and restricted cash	(29,871)	22,445
Cash and cash equivalents and restricted cash, beginning of period	48,839	26,394
Cash and cash equivalents and restricted cash, end of period	18,968	48,839
Supplemental Disclosure of Cash Flow Information
Interest	13,074	15,574
Income taxes	170	1,214
Non-Cash Transactions:
Contingent and deferred acquisition consideration	2,392	3,014
Stock-based compensation capitalized in property and equipment	635	469
Capital expenditures included in accounts payable	155	151
Issuance of equity for Crisp Results	0	10,000
Accretion and Dividends - Preferred Series A and B	11,653	0
Debt amendment fees paid-in-kind	5,410	0
Interest paid-in-kind	$ 23,482	$ 0